VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1552486
Sex: M
Age: 93
State: CT

Vax Date: 01/18/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Dizziness; A spontaneous report was received from a consumer who was also a 93-years-old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced dizziness. The patient's current condition included acid reflux. Products known to have been used by the patient, within two weeks prior to the event, included losartan not specific. On 18 Jan 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) via an unknown route for prophylaxis of COVID-19 infection. On an unspecified date patient started to experience dizziness. No treatment was provided. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable. The outcome of the event was not reported.

Other Meds: LOSARTAN

Current Illness: Acid reflux (oesophageal)

ID: 1552487
Sex: F
Age: 70
State: CA

Vax Date: 01/14/2021
Onset Date: 01/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: redness at injection site; A spontaneous report was received from a Health care professional concerning a 70 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced redness in injection site and it started to grow larger. The patient's medical history was not provided. Concomitant medications included Estrogen patch, Klonopin and Atorvastatin with unknown-indication were reported. On 14/Jan/2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection. On 20/Jan/2021, The patient experienced redness in injection site and it started to grow larger. Laboratory details were not provided. Patient was treated with Keflex 500mg twice a day, Zyrtec and warm compress. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event was resolved with the antibiotic. Patient would like to know whether she can take up the second dose and also would like to know the adverse event from clinical trials.

Other Meds: KLONOPIN; ESTROGEN Patch; ATORVASTATIN

Current Illness:

ID: 1552488
Sex: M
Age: 65
State: NJ

Vax Date: 02/17/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Experienced whole body itching and redness; Experienced whole body itching and redness; A spontaneous report was received from a consumer, concerning a male patient 65-year-old, who received Moderna's COVID-19 vaccine and experienced whole-body itching and redness. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection. On 17 FEB 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (lot/batch: 023M20A) via unknown route for prophylaxis of COVID-19 infection On 23 FEB 2021, the patient experienced whole-body itching and redness. Treatment details included Benadryl. Action taken with mRNA-1273 in response to the events was not reported. At the time of the report, the outcome of event was unknown.

Other Meds:

Current Illness:

ID: 1552489
Sex: F
Age: 68
State: FL

Vax Date: 01/12/2021
Onset Date: 02/10/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: a small slightly sore lump appeared on right side of lower neck, above collar bone; Swollen lymph nodes; This spontaneous case was reported by a patient and describes the occurrence of NECK MASS (a small slightly sore lump appeared on right side of lower neck, above collar bone) and LYMPHADENOPATHY (Swollen lymph nodes) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 039K20A) for COVID-19 vaccination. The patient's past medical history included Blood pressure high, Kidney stones, Osteopenia and High cholesterol. Concurrent medical conditions included Allergy to antibiotic (Bactrim) and Contrast media allergy (IVP dye). Concomitant products included AMLODIPINE, METOPROLOL SUCCINATE, CHLORTHALIDONE from 2018 to an unknown date, POTASSIUM CHLORIDE and ROSUVASTATIN for an unknown indication. On 12-Jan-2021 at 7:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021 at 7:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced NECK MASS (a small slightly sore lump appeared on right side of lower neck, above collar bone) and LYMPHADENOPATHY (Swollen lymph nodes). In February 2021, NECK MASS (a small slightly sore lump appeared on right side of lower neck, above collar bone) and LYMPHADENOPATHY (Swollen lymph nodes) had resolved. It was reported that the patient called an endocrinologist who confirmed it was probably a swollen lymph node. Swelling disappeared within a couple of days. No treatment medication was reported. This case was linked to MOD-2021-021697, MOD-2021-023928 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Email address updated On 29-Apr-2021: Followreceived on 29-04-2021 and contains No NewInformation On 07-Jul-2021: Patient demographics were updated. The patient's medical history and allergies were added. Suspect dosing details were updated. Concomitant medication was added. Events start date was updated. Outcome of events was updated.

Other Meds: AMLODIPINE; METOPROLOL SUCCINATE; CHLORTHALIDONE; POTASSIUM CHLORIDE; ROSUVASTATIN

Current Illness: Allergy to antibiotic (Bactrim); Contrast media allergy (IVP dye)

ID: 1552490
Sex: M
Age:
State: FL

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided. Treatment details were not provided. This case was linked to MOD-2021-022058 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Report: non safety info, updated address and email of the reporter

Other Meds:

Current Illness:

ID: 1552491
Sex: F
Age: 38
State: CA

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Pregnant patient received 1st dose of the vaccine; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of the vaccine) in a 38-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031m20a) for COVID-19 vaccination. Concurrent medical conditions included Allergy to animal (Allergy to bees reported.). Concomitant products included MULTIVITAMIN [VITAMINS NOS] and ASA for an unknown indication. On 20-Feb-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 02-Jul-2020 and the estimated date of delivery was 08-Apr-2021. On 20-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of the vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-third week of the pregnancy. On 20-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of the vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jul-2020, Pregnancy test positive: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information not reported. Estimated date of conception 14 Jul 2021.

Other Meds: MULTIVITAMIN [VITAMINS NOS]; ASA

Current Illness: Allergy to animal (Allergy to bees reported.)

ID: 1552492
Sex: F
Age: 78
State: OH

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: felt agitated; Fast heart beat 111 pulse; felt the eyes were burning; Had cold-hot flashes all day; Felt like she had a flu; Her eyes were blurry; Felt weak; Very tired; Her neck muscles were in pain; had nauseas; her arm was red below the injection site.; Itchiness at the injection site; 30 before the shot experienced Right arm hurting; Swollen arm,; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like she had a flu), VISION BLURRED (Her eyes were blurry), AGITATION (felt agitated), TACHYCARDIA (Fast heart beat 111 pulse) and EYE IRRITATION (felt the eyes were burning) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included SIMVASTATIN, VITAMINS NOS and ESCITALOPRAM for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm,), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE PAIN (30 before the shot experienced Right arm hurting). On 27-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like she had a flu), VISION BLURRED (Her eyes were blurry), TACHYCARDIA (Fast heart beat 111 pulse), EYE IRRITATION (felt the eyes were burning), HOT FLUSH (Had cold-hot flashes all day), ASTHENIA (Felt weak), FATIGUE (Very tired), MYALGIA (Her neck muscles were in pain), NAUSEA (had nauseas) and VACCINATION SITE ERYTHEMA (her arm was red below the injection site.). On 28-Jan-2021, the patient experienced AGITATION (felt agitated). The patient was treated with PARACETAMOL (TYLENOL) on 26-Jan-2021 for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Felt like she had a flu), VISION BLURRED (Her eyes were blurry), AGITATION (felt agitated), TACHYCARDIA (Fast heart beat 111 pulse), EYE IRRITATION (felt the eyes were burning), HOT FLUSH (Had cold-hot flashes all day), PERIPHERAL SWELLING (Swollen arm,), ASTHENIA (Felt weak), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE PAIN (30 before the shot experienced Right arm hurting), FATIGUE (Very tired), MYALGIA (Her neck muscles were in pain), NAUSEA (had nauseas) and VACCINATION SITE ERYTHEMA (her arm was red below the injection site.) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Body temperature: 92.7f (Inconclusive) 92.7F. On an unknown date, Tachycardia: 111 (Inconclusive) 111. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications simvastatin, vitamins, Escitalopram. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: No specific follow-up information recorded.

Other Meds: SIMVASTATIN; VITAMINS NOS; ESCITALOPRAM

Current Illness:

ID: 1552493
Sex: F
Age: 29
State: OH

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Received first dose of the vaccine and was pregnant; A spontaneous report was received from a other healthcare professional concerning 29 years old, pregnant female patient, who received Moderna's Covid-19 Vaccine (mRNA-1273) during pregnancy (Vaccine exposure during pregnancy). The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 17 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 011M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 17 Feb 2021, the pregnant patient was exposed to the mRNA-1273 vaccine. Her last menstrual period and conception date was unknown. The patient's estimated due date is on date. The patient's treatment included prenatal vitamins and baby aspirin. Action taken with mRNA-1273 in response to the event was not provided. The outcome of the event received first dose of the vaccine and was pregnant was considered resolved on 17-Feb-2021.; Reporter's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 29-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.

Other Meds:

Current Illness:

ID: 1552494
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Felt really bad that day, the next day he was fine.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 23-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt really bad that day, the next day he was fine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt really bad that day, the next day he was fine.). At the time of the report, MALAISE (Felt really bad that day, the next day he was fine.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD21-036175, MOD21-036103 (E2B Linked Report).; Sender's Comments: MOD21-036175: MOD21-036103:

Other Meds:

Current Illness:

ID: 1552495
Sex: F
Age: 69
State: TX

Vax Date: 01/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Slept for 17 hours; Arm hurt; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jan-2021 and was forwarded to Moderna on 29-Jan-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt) and SOMNOLENCE (Slept for 17 hours) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0137K20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm hurt). On 02-Jan-2021, the patient experienced SOMNOLENCE (Slept for 17 hours). On 31-Dec-2020, PAIN IN EXTREMITY (Arm hurt) had resolved. On 03-Jan-2021, SOMNOLENCE (Slept for 17 hours) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1552496
Sex: F
Age: 25
State: TX

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Body aches; Pain; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PAIN (Pain), CHILLS (Chills) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (Body aches), PAIN (Pain), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, PAIN (Body aches), PAIN (Pain), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant Medication not provided by the reporter. Treatment information was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1552497
Sex: M
Age:
State: GA

Vax Date: 01/25/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: some aches; Nausea; Vomitting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (some aches), NAUSEA (Nausea) and VOMITING (Vomitting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced PAIN (some aches), NAUSEA (Nausea) and VOMITING (Vomitting). At the time of the report, PAIN (some aches), NAUSEA (Nausea) and VOMITING (Vomitting) outcome was unknown. Action taken with mRNA-1273 in response to the event was not applicable. Concomitant Medication not provided by the reporter. Treatment information was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1552498
Sex: F
Age: 52
State: NY

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Heaviness in my chest / tightness in my chest; Severe abdominal pain; Low back ache; Severe abdominal discomfort; Lupus rash (neck, trunk, chest, then my arms and legs on the next day); No appetite; Chills; Fever (103?F); Fatigue; Soreness @ injection site; Swelling @ injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort) and SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Cutaneous lupus erythematosus. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache). On 26-Jan-2021, the patient experienced CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), CHILLS (Chills), PYREXIA (Fever (103?F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site). At the time of the report, CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever (103?F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness: Cutaneous lupus erythematosus

ID: 1552499
Sex: F
Age: 79
State: AL

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Redness at the injection site and red/red streak down the arm went away after 3 days; site was really red and sore; red, itching rash came back on her arm and lasted about 11 days; itching rash came back on her arm and lasted about 11 days; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site and red/red streak down the arm went away after 3 days), VACCINATION SITE PAIN (site was really red and sore), VACCINATION SITE ERYTHEMA (red, itching rash came back on her arm and lasted about 11 days) and VACCINATION SITE PRURITUS (itching rash came back on her arm and lasted about 11 days) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site and red/red streak down the arm went away after 3 days), VACCINATION SITE PAIN (site was really red and sore), VACCINATION SITE ERYTHEMA (red, itching rash came back on her arm and lasted about 11 days) and VACCINATION SITE PRURITUS (itching rash came back on her arm and lasted about 11 days). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site reaction, at an unspecified dose and frequency. On 20-Jan-2021, VACCINATION SITE ERYTHEMA (Redness at the injection site and red/red streak down the arm went away after 3 days) had resolved. On 28-Jan-2021, VACCINATION SITE ERYTHEMA (red, itching rash came back on her arm and lasted about 11 days) and VACCINATION SITE PRURITUS (itching rash came back on her arm and lasted about 11 days) had resolved. At the time of the report, VACCINATION SITE PAIN (site was really red and sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant Medication not provided by the reporter. This case was linked to MOD-2021-011101 (Parent-Child Link). This case was linked to MOD-2021-011101 (Patient Link). See case MOD-2021-011101 for details regarding the child case. Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1552500
Sex: F
Age:
State: NE

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Under the armpit it feels tender; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Under the armpit it feels tender) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 040A20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 17-Feb-2021 at 5:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021 at 5:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Under the armpit it feels tender). At the time of the report, AXILLARY PAIN (Under the armpit it feels tender) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Treatment details not provided by the reporter. The tenderness started a couple of days after the first dose and was gone approximately 4 to 5 days later. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Reporter details updated, patient's demographics updated, second dose vaccine information added and outcome of the event was updated from unknown to recovered.

Other Meds: BABY ASPIRIN

Current Illness:

ID: 1552501
Sex: F
Age: 73
State: OH

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Stomach hurting; sore throat; fatigue; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach hurting), OROPHARYNGEAL PAIN (sore throat), FATIGUE (fatigue), NAUSEA (nausea) and VOMITING (vomiting) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Cholesterol. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach hurting), OROPHARYNGEAL PAIN (sore throat), FATIGUE (fatigue), NAUSEA (nausea) and VOMITING (vomiting). In February 2021, OROPHARYNGEAL PAIN (sore throat) and VOMITING (vomiting) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Stomach hurting), FATIGUE (fatigue) and NAUSEA (nausea) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient take Tylenol and aspirin since 21Feb2021 as a Treatment medication This case was linked to MOD-2021-022241, MOD-2021-022272.

Other Meds:

Current Illness: Cholesterol; Hypertension

ID: 1552502
Sex: F
Age: 80
State: CA

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: pain in her arm where the vaccine was injected; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in her arm where the vaccine was injected) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain in her arm where the vaccine was injected). At the time of the report, VACCINATION SITE PAIN (pain in her arm where the vaccine was injected) had resolved. No concomitant medications were provided No treatment information provided Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: follow-up received document Addition of second dose information added , outcome of event Vaccination site pain is changes from unknown to recovered, No further follow-up required.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1552503
Sex: F
Age: 40
State: TX

Vax Date: 01/20/2021
Onset Date: 02/02/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: she felt very light headed; her top gum of the right hand side started getting very tingly; her top gum of the right hand side started burning; she could feel her gum swelling/really swollen; got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red; Burning like they were on fire/burning for all night long; her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen) and GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included FAMOTIDINE, CETIRIZINE, TRIAMCINOLONE and SEMAGLUTIDE for an unknown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HYPOAESTHESIA (her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb). On 20-Feb-2021, the patient experienced DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen), GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red) and GINGIVAL DISCOMFORT (Burning like they were on fire/burning for all night long). On 21-Feb-2021, DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen), GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red), GINGIVAL DISCOMFORT (Burning like they were on fire/burning for all night long) and HYPOAESTHESIA (her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: FAMOTIDINE; CETIRIZINE; TRIAMCINOLONE; SEMAGLUTIDE

Current Illness:

ID: 1552504
Sex: F
Age: 52
State: KS

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: developed a severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (developed a severe headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (developed a severe headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, HEADACHE (developed a severe headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1552505
Sex: F
Age: 75
State: PR

Vax Date: 01/12/2021
Onset Date: 01/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Itchiness all over the body/Itchiness in cycles; Discomfort; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (Itchiness all over the body/Itchiness in cycles) and DISCOMFORT (Discomfort) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011H20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes since 1994, Blood pressure high since 1975, Hyperlipidaemia since 1985 and Penicillin allergy (Itching on the lips.Happened more than 50 years ago and she had not used it again.). Concomitant products included ATORVASTATIN for Cholesterol, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET XR) for Diabetes, IRBESARTAN and NIFEDIPINE for Hypertension. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PRURITUS (Itchiness all over the body/Itchiness in cycles) and DISCOMFORT (Discomfort). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) from 21-Jan-2021 to 23-Jan-2021 at a dose of 50 mg three times a day. On 23-Jan-2021, PRURITUS (Itchiness all over the body/Itchiness in cycles) had resolved. At the time of the report, DISCOMFORT (Discomfort) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up information received on 30-JUN-2021. Reporter phone number updated, second dose added, action taken and event outcome updated.

Other Meds: ATORVASTATIN; JANUMET XR; IRBESARTAN; NIFEDIPINE

Current Illness: Blood pressure high; Diabetes; Hyperlipidaemia; Penicillin allergy (Itching on the lips.Happened more than 50 years ago and she had not used it again.)

ID: 1552506
Sex: F
Age: 89
State: OH

Vax Date: 01/25/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Blood thinner then before; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD DISORDER (Blood thinner then before) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029120A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced BLOOD DISORDER (Blood thinner then before). At the time of the report, BLOOD DISORDER (Blood thinner then before) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient is on blood thinner. Treatment details not provided.

Other Meds:

Current Illness:

ID: 1552507
Sex: F
Age: 71
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Swollen; Hot; rash; big hives, sizes of a counter; Migraine and headache; Red arm; migraine and headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine and headache), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen), FEELING HOT (Hot) and RASH (rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MIGRAINE (Migraine and headache), ERYTHEMA (Red arm) and HEADACHE (migraine and headache). On 22-Feb-2021, the patient experienced RASH (rash) and URTICARIA (big hives, sizes of a counter). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen) and FEELING HOT (Hot). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. On 20-Feb-2021, MIGRAINE (Migraine and headache) and HEADACHE (migraine and headache) had resolved. At the time of the report, ERYTHEMA (Red arm), RASH (rash) and URTICARIA (big hives, sizes of a counter) had not resolved and PERIPHERAL SWELLING (Swollen) and FEELING HOT (Hot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1552508
Sex: M
Age: 29
State: NY

Vax Date: 01/19/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: dizziness; clamminess; lost feeling in my arms, wrist; fingers curled; pain at the injection site; Fatigue; bodyaches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled) and VACCINATION SITE PAIN (pain at the injection site) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea). At the time of the report, DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea) had not resolved. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1552509
Sex: M
Age:
State: IN

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: muscular problems; chills; fever; nauseas; body pain; diarrhea; night sweats; didn't feel well; felt funny; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well) and FEELING ABNORMAL (felt funny) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (Test was negative but he had all the symptoms for 6 weeks) on 31-Oct-2020. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well), FEELING ABNORMAL (felt funny), CHILLS (chills), PYREXIA (fever) and NAUSEA (nauseas). On 22-Feb-2021, the patient experienced MUSCULAR WEAKNESS (muscular problems). At the time of the report, PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well), FEELING ABNORMAL (felt funny), MUSCULAR WEAKNESS (muscular problems), CHILLS (chills), PYREXIA (fever) and NAUSEA (nauseas) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided No treatment information provided Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1552510
Sex: F
Age: 75
State: WI

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Left arm was hurting at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm was hurting at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (Left arm was hurting at injection site). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site pain, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (Left arm was hurting at injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Additional information received included no new information.

Other Meds:

Current Illness:

ID: 1552511
Sex: M
Age: 79
State: OH

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: stomach hurting; he is not hungry, he does not eat; has lost like 3 poungds but he does not feel critical; Symptoms still ongoing; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing) and NAUSEA (nausea) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure and Cholesterol. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing), NAUSEA (nausea) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) on 21-Feb-2021 for Nausea and Abdominal pain, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPRIN) on 21-Feb-2021 for Nausea and Abdominal pain, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing), NAUSEA (nausea) and FATIGUE (fatigue) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD21-036175, MOD21-036214 (E2B Linked Report).; Sender's Comments: MOD21-036175: MOD21-036214:

Other Meds:

Current Illness: Blood pressure; Cholesterol

ID: 1552512
Sex: F
Age: 76
State: AL

Vax Date: 01/18/2021
Onset Date: 01/27/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: scratching, itchiness at site of injection; rash in area of injection 2 in diameter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (scratching, itchiness at site of injection) and VACCINATION SITE RASH (rash in area of injection 2 in diameter) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (scratching, itchiness at site of injection) and VACCINATION SITE RASH (rash in area of injection 2 in diameter). At the time of the report, VACCINATION SITE PRURITUS (scratching, itchiness at site of injection) and VACCINATION SITE RASH (rash in area of injection 2 in diameter) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Neosporin taken as a Treatment medication.

Other Meds:

Current Illness:

ID: 1552513
Sex: F
Age: 35
State: AR

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: hives around injection site; rash around injection site; itchiness at injection site; warmth at injection site; bump at the injection site; A spontaneous report was received from a consumer concerning a 35-year-old, mfeale patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site urticaria,injection site pruritis,injection site warmth,injection site mass and injection site rash. The patient's medical history was unknown.. Concomitant medications were unknown. On 21-JAN-2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 21-JAN-2021, prior to receiving mRNA-1273, the patient felt warmth and a bump at the injection site and went away followed by random itchiness and on 27-JAN-2021 injection site warm and itchy surrounded by a rash and hives. Treatment for the events was unknown. Action taken with mRNA-1273 in response to the events was unknown. The outcome of the events,injection site mass , were considered resolved and outcome of injection site urticaria,injection site pruritis,injection site warmth,injection site rash were considered unknown.

Other Meds:

Current Illness:

ID: 1552514
Sex: F
Age: 75
State: NY

Vax Date: 02/07/2021
Onset Date: 02/15/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: delayed injection site reaction that continue for a week still, although now it is fainting; reaction consisted of inflammation in the arm of the injection, it was red, hot, painful, itchy ,and burnt. It got worse by Tuesday, spread, became diffuse, but better around Wednesday. Now there is a faint ring around area affected; injection site that was red; injection site that was hot; injection site that was painful; injection site that was itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (delayed injection site reaction that continue for a week still, although now it is fainting), VACCINATION SITE INFLAMMATION (reaction consisted of inflammation in the arm of the injection, it was red, hot, painful, itchy ,and burnt. It got worse by Tuesday, spread, became diffuse, but better around Wednesday. Now there is a faint ring around area affected), VACCINATION SITE ERYTHEMA (injection site that was red), VACCINATION SITE WARMTH (injection site that was hot) and VACCINATION SITE PAIN (injection site that was painful) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Primary biliary cholangitis (Began ursodiol therapy when condition was diagnosed in 2020, but chronically elevated liver enzymes suggest that the condition.) on 06-Jan-2020. Concurrent medical conditions included Hypertension (Mild.Improvement since diagnosis; no change in valsartan dosage) since 01-May-2009 and Penicillin allergy. Concomitant products included VALSARTAN from 05-May-2009 to an unknown date for Hypertension, AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLLINE) from 15-Aug-2018 to an unknown date for Irritable bowel syndrome, MULTIVITAMINS & MINERALS PLUS LUTEIN for Nutritional supplement, URSODEOXYCHOLIC ACID (URSODIL) from 06-Jan-2020 to an unknown date for Primary biliary cholangitis. On 07-Feb-2021 at 4:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE REACTION (delayed injection site reaction that continue for a week still, although now it is fainting), VACCINATION SITE WARMTH (injection site that was hot), VACCINATION SITE PAIN (injection site that was painful) and VACCINATION SITE PRURITUS (injection site that was itchy). 15-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (reaction consisted of inflammation in the arm of the injection, it was red, hot, painful, itchy ,and burnt. It got worse by Tuesday, spread, became diffuse, but better around Wednesday. Now there is a faint ring around area affected) and VACCINATION SITE ERYTHEMA (injection site that was red). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse reaction, at an unspecified dose and frequency and HYDROCORTISONE (HYDROCORTISONE 1% IN ABSORBASE) for Adverse reaction to product, at an unspecified dose and frequency. On 22-Feb-2021, VACCINATION SITE REACTION (delayed injection site reaction that continue for a week still, although now it is fainting) and VACCINATION SITE INFLAMMATION (reaction consisted of inflammation in the arm of the injection, it was red, hot, painful, itchy ,and burnt. It got worse by Tuesday, spread, became diffuse, but better around Wednesday. Now there is a faint ring around area affected) had resolved and VACCINATION SITE ERYTHEMA (injection site that was red), VACCINATION SITE WARMTH (injection site that was hot), VACCINATION SITE PAIN (injection site that was painful) and VACCINATION SITE PRURITUS (injection site that was itchy) outcome was unknown. This case was linked to MOD-2021-022333, MOD-2021-117565 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received Included second dose information, allergy, historical conditions, concomitant drugs, events. On 11-May-2021: NNI

Other Meds: VALSARTAN; URSODIL; MULTIVITAMINS & MINERALS PLUS LUTEIN; AMITRIPTYLLINE

Current Illness: Hypertension (Mild.Improvement since diagnosis; no change in valsartan dosage); Penicillin allergy

ID: 1552515
Sex: F
Age: 76
State: MI

Vax Date: 01/25/2021
Onset Date: 01/27/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: bad case of diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (bad case of diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DIARRHOEA (bad case of diarrhea). On 29-Jan-2021, DIARRHOEA (bad case of diarrhea) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details not provided

Other Meds:

Current Illness:

ID: 1552516
Sex: F
Age: 87
State: AZ

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: couldn't eat; Vomited; Very weak/felt so weak; Chills; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (couldn't eat), ASTHENIA (Very weak/felt so weak), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Autoimmune disorder NOS (two autoimmune diseases, one in eye). Concomitant products included METHOTREXATE for an unknown indication. On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ASTHENIA (Very weak/felt so weak), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache). On 21-Feb-2021, the patient experienced DECREASED APPETITE (couldn't eat) and VOMITING (Vomited). On 17-Feb-2021, HEADACHE (Headache) had resolved. On 21-Feb-2021, VOMITING (Vomited) had resolved. At the time of the report, DECREASED APPETITE (couldn't eat), ASTHENIA (Very weak/felt so weak), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. No treatment information provided Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow up information received on 29-jun-2021 contains email address updated

Other Meds: METHOTREXATE

Current Illness:

ID: 1552517
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: things going on with their eyes, same side as injection; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (things going on with their eyes, same side as injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OCULAR DISCOMFORT (things going on with their eyes, same side as injection). At the time of the report, OCULAR DISCOMFORT (things going on with their eyes, same side as injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications provided.

Other Meds:

Current Illness:

ID: 1552518
Sex: F
Age: 81
State: MA

Vax Date: 02/13/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: a large redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (a large redness on the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure abnormal and Colitis. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (a large redness on the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (a large redness on the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medications included blood pressure medications and colitis medication

Other Meds:

Current Illness: Blood pressure abnormal; Colitis

ID: 1552519
Sex: F
Age: 87
State:

Vax Date: 01/17/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: upper arm is swollen; upper arm is a little pink; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (upper arm is swollen) and ERYTHEMA (upper arm is a little pink) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (upper arm is swollen) and ERYTHEMA (upper arm is a little pink). At the time of the report, PERIPHERAL SWELLING (upper arm is swollen) and ERYTHEMA (upper arm is a little pink) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1552520
Sex: M
Age: 57
State: TX

Vax Date: 01/18/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024A20A and 042L20A) for COVID-19 vaccination. The patient's past medical history included Cancer and Liver transplant. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). On 23-Feb-2021, CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) had resolved.

Other Meds:

Current Illness:

ID: 1552521
Sex: F
Age: 52
State: MD

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: severe muscle spasm; Chills everyday for one month; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (severe muscle spasm) and CHILLS (Chills everyday for one month) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02520A) for COVID-19 vaccination. The patient's past medical history included No adverse event . Concomitant products included TOFACITINIB CITRATE (XELJANZ) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (severe muscle spasm) and CHILLS (Chills everyday for one month). At the time of the report, MUSCLE SPASMS (severe muscle spasm) and CHILLS (Chills everyday for one month) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds: XELJANZ

Current Illness:

ID: 1552522
Sex: M
Age: 77
State: TX

Vax Date: 01/15/2021
Onset Date: 02/13/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Rash at the site of shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the site of shot) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041120A and 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high and Diabetes. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the site of shot). On 27-Feb-2021, VACCINATION SITE RASH (Rash at the site of shot) had resolved. No concomitant medications were reported Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: On 03-May-2021: Reporter details updated, dose details updated, event details updated and medical history added.

Other Meds:

Current Illness: Blood pressure high; Diabetes

ID: 1552523
Sex: F
Age:
State: TX

Vax Date: 02/06/2021
Onset Date: 02/06/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: m injection site was a little tender; charlie horse in upper right thigh/charlie horse in part of inner leg; chest started tightening up a little bit; chest pain; could hardly walk; nagging headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (m injection site was a little tender), MUSCLE SPASMS (charlie horse in upper right thigh/charlie horse in part of inner leg), CHEST DISCOMFORT (chest started tightening up a little bit), CHEST PAIN (chest pain) and GAIT INABILITY (could hardly walk) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. . Concomitant products included HYDRALAZINE, AMLODIPINE, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and UBIDECARENONE (COQ) for an unknown indication. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced MUSCLE SPASMS (charlie horse in upper right thigh/charlie horse in part of inner leg), CHEST DISCOMFORT (chest started tightening up a little bit), CHEST PAIN (chest pain), GAIT INABILITY (could hardly walk) and HEADACHE (nagging headache). On an unknown date, the patient experienced INJECTION SITE PAIN (m injection site was a little tender). On 07-Feb-2021, MUSCLE SPASMS (charlie horse in upper right thigh/charlie horse in part of inner leg), CHEST DISCOMFORT (chest started tightening up a little bit), CHEST PAIN (chest pain), GAIT INABILITY (could hardly walk) and HEADACHE (nagging headache) had resolved. At the time of the report, INJECTION SITE PAIN (m injection site was a little tender) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: HYDRALAZINE; AMLODIPINE; VITAMIN C & ROSEHIP; COQ

Current Illness:

ID: 1552524
Sex: F
Age: 70
State: TX

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: woke up feeling hot; had a fever of 99.8 F; A spontaneous report was received from a consumer concerning, a 70-year-old female patient, who received Moderna (mRNA-1273) vaccine and woke up feeling hot and had a fever of 99.8 F. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 27 Jan 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: 043L20A) in the left arm for prophylaxis of COVID-19 infection. On 27 Jan 2021 at 10:30 PM, the patient went to bed and slept until 3 AM and woke up feeling hot. The patient had a fever of 99.8 F. The patient went back to sleep and when woke up the fever was gone. The patient stayed up for 2 hours and then slept until 2 PM. The reporter stated that the patient had the best sleep they had in a long time. Treatment information was not provided by the reporter. Action taken with mRNA-1273 in response to the event(s) was Not Applicable. On 28 Jan 2021, the outcome of the events, woke up feeling hot and had a fever of 99.8 F were considered resolved.

Other Meds:

Current Illness:

ID: 1552525
Sex: U
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Had a 20 inches red induration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INDURATION (Had a 20 inches red induration) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (Had a 20 inches red induration). At the time of the report, VACCINATION SITE INDURATION (Had a 20 inches red induration) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-021564, MOD-2021-010050 (Patient Link).

Other Meds:

Current Illness:

ID: 1552526
Sex: F
Age: 85
State: MI

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Heart Racing at Night; Body Aches; Fever - Temperature of 101.0F; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Heart Racing at Night), PAIN (Body Aches), PYREXIA (Fever - Temperature of 101.0F) and FATIGUE (Fatigue) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PALPITATIONS (Heart Racing at Night), PAIN (Body Aches), PYREXIA (Fever - Temperature of 101.0F) and FATIGUE (Fatigue). At the time of the report, PALPITATIONS (Heart Racing at Night), PAIN (Body Aches), PYREXIA (Fever - Temperature of 101.0F) and FATIGUE (Fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 101.0f (Inconclusive) 101.0F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided No treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1552527
Sex: M
Age:
State: CT

Vax Date: 12/12/2020
Onset Date: 01/15/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: jaw pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (jaw pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. Concomitant products included COLECALCIFEROL (VIT D [COLECALCIFEROL]) and CYANOCOBALAMIN (VIT B 12) for an unknown indication. On 12-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN JAW (jaw pain). At the time of the report, PAIN IN JAW (jaw pain) had not resolved.

Other Meds: VIT D [COLECALCIFEROL]; VIT B 12

Current Illness:

ID: 1552528
Sex: F
Age: 72
State: MI

Vax Date: 02/08/2021
Onset Date: 02/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Chest congestion; Coughing; Runny nose; Sore ribs; Stopped up nose; head congestion; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (head congestion), CHEST DISCOMFORT (Chest congestion), COUGH (Coughing), RHINORRHOEA (Runny nose) and MUSCULOSKELETAL CHEST PAIN (Sore ribs) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEAD DISCOMFORT (head congestion). On an unknown date, the patient experienced CHEST DISCOMFORT (Chest congestion), COUGH (Coughing), RHINORRHOEA (Runny nose), MUSCULOSKELETAL CHEST PAIN (Sore ribs) and NASAL CONGESTION (Stopped up nose). At the time of the report, HEAD DISCOMFORT (head congestion) had resolved and CHEST DISCOMFORT (Chest congestion), COUGH (Coughing), RHINORRHOEA (Runny nose), MUSCULOSKELETAL CHEST PAIN (Sore ribs) and NASAL CONGESTION (Stopped up nose) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided No treatment information provided; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1552529
Sex: F
Age: 72
State: MI

Vax Date: 02/08/2021
Onset Date: 02/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Coughing; Runny nose; Stopped up nose; Sore ribs; Chest congestion; Head congestion; A spontaneous report was received from a consumer concerning a 72-years-old, female patient who experienced chest congestion, head congestion/stopped up nose , coughing, runny nose, and sore ribs. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 08 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (lot number: 013M20A) intramuscularly for prophylaxis of COVID-19 infection. On 17 Feb 2021, the patient reported head congestion that resolved on unknown date. She also reported chest congestion, coughing, runny nose, stopped up nose and sore ribs. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events, chest congestion, head congestion/stopped up nose, coughing, runny nose, and sore ribs, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1552530
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Adverse reactions; A spontaneous report was received from a pharmacist concerning unspecified patients, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced adverse reactions. The patient's medical history, was not provided by the reporter. Concomitant medications were not reported. On an unknown date, prior to the onset of the events, the patient received their planned dose of mRNA-1273 (Lot number: unknown) via an unknown route for prophylaxis of COVID-19 infection. On an unknown date the patients experienced adverse reactions. Treatment for the events were not reported. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, adverse reactions were unknown

Other Meds:

Current Illness:

ID: 1552531
Sex: F
Age:
State: IL

Vax Date: 02/15/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: warm to touch at the injection site, it is not painful.; has a little rash around the injection site; little red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch at the injection site, it is not painful.), VACCINATION SITE RASH (has a little rash around the injection site) and VACCINATION SITE ERYTHEMA (little red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch at the injection site, it is not painful.), VACCINATION SITE RASH (has a little rash around the injection site) and VACCINATION SITE ERYTHEMA (little red). At the time of the report, VACCINATION SITE WARMTH (warm to touch at the injection site, it is not painful.), VACCINATION SITE RASH (has a little rash around the injection site) and VACCINATION SITE ERYTHEMA (little red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided No treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1552532
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Shingles due to the vaccination; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced shingles due to the vaccination/herpes zoster. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: UNKNOWN) via unknown route for prophylaxis of COVID-19 infection.On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: UNKNOWN) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced shingles due to the vaccination/herpes zoster.. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. on an unknown date the outcome of shingles due to the vaccination/herpes zoster. due to the vaccination was unknown.

Other Meds:

Current Illness:

ID: 1552533
Sex: F
Age: 83
State: NY

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: tested positive for covid; cough; muscle pain; Fever; very week; This spontaneous report was reported by an other health care professional and describes the occurrence of MYALGIA (muscle pain), ASTHENIA (very weak), COVID-19 (tested positive for covid), COUGH (cough) and PYREXIA (Fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient had no medical history On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (muscle pain), ASTHENIA (very weak), COUGH (cough) and PYREXIA (Fever). On 19-Jan-2021, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, MYALGIA (muscle pain), ASTHENIA (very weak), COVID-19 (tested positive for COVID) and COUGH (cough) outcome was unknown. The outcome for the patient being tested with COVID-19 is unlikely because of the vaccine. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1552534
Sex: F
Age: 54
State: MA

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Diarrhea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Headache). At the time of the report, DIARRHOEA (Diarrhea) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided No treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1552535
Sex: F
Age: 68
State: PA

Vax Date: 01/23/2021
Onset Date: 01/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Metalic taste in mouth; paresthesia both legs; shooting pain down my back; felt like legs were shrink wrapped; under skin numbness; left arm sore; tired all over; pins and needles down both legs; A spontaneous report was received from a 68-years-old female patient concerning herself who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events left arm sore, tired all over, legs felt frozen, under skin numbness, felt like legs were shrink wrapped, shooting pain down back, pins and needles down both legs, paresthesia both legs and metallic taste in mouth. The patient's medical history was provided as auto immune connective tissue disease. No relevant concomitant medications were reported. On 23 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 25 J an 2021, the patient experienced events legs were (felt like they were) frozen, feeling numbness under the skin. On 26 Jan 2021 and it felt like they were shrink wrapped. On 27 Jan 2021 felt shooting pain down back, it lasted about five hours. On an unknown date, the patient had pins and needles down both legs, that have continued since it started. On 19 Feb 2021 the patient had metallic taste in my mouth. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. On 27 Jan 2021, the event shooting pain down back was considered recovered. The outcome of events, left arm sore, tired all over, legs felt frozen, under skin numbness, felt like legs were shrink wrapped, pins and needles down both legs, paresthesia both legs and metallic taste in mouth was unknown.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm